Deutsche Bank raised the firm’s price target on PGT Innovations to $33 from $29 and keeps a Buy rating on the shares. On Thursday, PGT Innovations announced that its board approved the adoption of a limited-duration shareholder rights plan, which the firm views as "entirely justified" based on where the stock has been trading, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PGTI:
- PGT Innovations Surges as Poison Pill Plan Emerges
- Jefferies says $33-plus share price ‘reasonable’ for PGT Innovations in takeover
- PGT Innovations adopts limited-duration shareholder rights plan
- PGT Innovations sees Q1 revenue $370M-$390M , consensus $365.3M
- PGT Innovations reports Q4 EPS 27c, consensus 28c